Fidelity Disruptive Medicine Fund RPRX Holdings History
Fidelity Disruptive Medicine Fund's Royalty Pharma PLC Holding Summary
As of 2023-05-31, FIDELITY SUMMER STREET TRUST held 41,554.00 shares of Royalty Pharma PLC(RPRX), totaling $1.36 Mil. This investment constitutes 3.16% of their stock portfolio, and FIDELITY SUMMER STREET TRUST now holds 0.01% of the outstanding Royalty Pharma PLC(RPRX) stock.
The initial trade took place in 2020Q3. And since then Fidelity Disruptive Medicine Fund has made 5 purchases of RPRX, at an average price of $43.16, for a total of 66,214.00 shares. In addition, there have been 5 sales at an average price of $41.42 for 24,660.00 shares. Based on historical transaction data and RPRX's current price of $35.91, Fidelity Disruptive Medicine Fund's estimated gain on his RPRX holdings is $-344,108.93, reflecting a -12.04% gain to date.
Fidelity Disruptive Medicine Fund RPRX ($35.91) Holding Chart
Fidelity Disruptive Medicine Fund RPRX ($35.91) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1